We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
1,2,3,4,5 Department of Pharmaceutics, Shri Sai Janvikas Pratisthan’s Shri Sai College of Pharmacy, Lonere, India
6Dermalogics, Mumbai, India
Oleogels offer promising non-aqueous platforms for the delivery of lipophilic and structurally sensitive compounds; however, single-gelator systems may provide limited control over mechanical strength, rheological behaviour, and physical stability. This study developed and evaluated hybrid oleogels incorporating polymeric, wax-based, and multifunctional structuring agents to investigate the effect of combined gelation mechanisms on formulation performance. Single-component and hybrid systems were evaluated for appearance, viscosity, rheological behaviour, spreadability, firmness, consistency, oil-binding capacity, microscopic characteristics, in-vitro release, and stability. The optimized hybrid oleogels exhibited a homogeneous appearance, smooth texture, self-supporting structure, improved consistency, and minimal oil leakage, indicating effective oil immobilization and enhanced structural stability. Increasing gelator concentration increased viscosity, while hybrid systems demonstrated improved rheological profiles compared with individual gelator systems. The optimized formulations also showed balanced firmness, smooth spreading, good cohesiveness, and rapid structural recovery. These findings indicate that combining complementary gelation mechanisms can generate structurally robust oleogels with tuneable rheological and mechanical properties. The developed hybrid systems therefore demonstrate potential as advanced non-aqueous platforms for the pharmaceutical delivery of lipophilic compounds.
The human skin functions as an advanced physiological barrier and regulates critical baseline parameters including hydration, thermal distribution, and immune defense [cite: 1]. However, the dense arrangement of the stratum corneum strictly limits the transdermal permeation of many therapeutic and cosmetic compounds [cite: 1]. Conventional topical delivery vehicles such as creams, ointments, emulsions, and hydrogels often exhibit processing limitations including phase separation, high microbial susceptibility, poor chemical stability of moisture-sensitive actives, and low loading capacities for lipophilic molecules [cite: 1]. These persistent issues have driven substantial formulation interest toward lipid-based, completely non-aqueous structuring networks [cite: 1].
Oleogels are semi-solid systems formed by immobilizing organic liquid oils within a continuous three-dimensional structural network generated by organic oleogelators [cite: 1]. These platforms uniquely combine the lipid solubilization and biocompatibility advantages of standard vehicle oils with the rigid mechanical properties of structural gels [cite: 1]. Oleogels significantly enhance the stability of lipophilic and oxidation-sensitive active ingredients, optimize residence retention times, and allow for programmable controlled release kinetics by modifying the internal network architecture [cite: 1].
Recent research has focused closely on hybrid multi-component oleogel systems that integrate distinct classes of gelling agents—such as structural polymers, wax-based crystallizers, and supramolecular assemblies—to achieve enhanced mechanical strength, stable rheological behavior, and exceptional physical durability compared to single-gelator configurations [cite: 1]. In the present study, Caprylic/Capric Triglyceride (MCT oil) and Light Liquid Paraffin (LLP) were evaluated as lipid phases of different polarities [cite: 1]. Concurrently, Ethyl cellulose, Kester Wax, DOWSIL Resin Wax, Dextrin Palmitate, and Ellamera polymers were incorporated to construct advanced hybrid oleogel delivery networks [cite: 1].
2. MATERIALS AND METHODS
2.1 Materials
Caprylic/Capric Triglyceride (Radia 7104) and Light Liquid Paraffin (LLP) were utilized as primary vectors. Excipients used include Hydrocel-EC, Ellamera Bi-Thin 602, Septon 4055, DOWSIL SW-8005 C30, Kester Wax K80P, Kester K62P, Evercel GP1, Evergel EG-EB 21, TAISECT-OG-C MB, Rheopearl KL2, AEROSIL®, and SAFICOIL [cite: 1].
2.2 Methods of Preparation
The oleogel matrices were formulated using a standardized heating-cooling technique [cite: 1]. The vehicle oil was accurately heated to 70–120°C [cite: 1]. Under steady agitation (300–600 rpm), structuring agents were sequentially introduced based on individual dissolution properties: high-melting polymers first, followed by crystalline waxes and low molecular weight gelators at intermediate ranges (80–100°C), and particulate thickeners last [cite: 1]. Clear solutions were cooled to ambient conditions to yield three-dimensional semi-solid networks, cast into geometries, and allowed to equilibrate for 24 hours prior to technical evaluation [cite: 1].
2.3 Technical Evaluation Techniques
Organoleptic visual parameters were recorded [cite: 1]. Viscosity parameters were verified on a Brookfield Digital Viscometer (DV-I Prime) using RV spindles and T-Bar Helipath setups (10–20 rpm) [cite: 1]. Texture Profile Analysis (TPA) parameters were explicitly captured via a digital Texture Analyzer operating with a TTC Spreadability Rig (HDP/SR) and a Forward Extrusion Assembly (A/FE) [cite: 1].
3. RESULTS AND DISCUSSION
3.1 Screening and Table Characterization
|
Formulation Code |
Primary Gelator System |
Concentration (%) |
Secondary Modifiers |
Phase Sep (24H) |
Macroscopic Visual Remark |
|
OG-1 |
C30 Resin Wax |
16% |
None |
No |
Strong structuring; high opacity |
|
OG-2 |
Dextrin Palmitate |
10% |
None |
No |
Acceptable thickening; clarity intermediate |
|
OG-3 |
TAISECT OG-C MB |
6% |
None |
No |
Medium-firm gel; homogeneous translucent finish |
|
OG-4 |
Ellamera Bi-Thin 602 |
6% |
None |
No |
Clear transparent gel; high elasticity |
|
OG-5 |
Kester Wax K80P |
20% |
Cetearyl Behenate |
No |
Strong wax structuring; white salve |
|
OG-6 |
Ethyl cellulose |
8% |
None |
No |
Firm cohesive structure; slightly yellowish |
|
OG-7 |
Septon 4055 |
10% |
None |
No |
Clear transparent gel; high drag |
|
OG-8 |
Colloidal Silica |
10% |
None |
No |
Highly transparent; thick particle paste |
|
OG-9 |
SAFICOIL System |
8% |
None |
No |
Viscous translucent gel; smooth texture |
|
OG-10 |
Glutamide Blend |
4% |
Evercel GP1 + Evergel EG |
No |
Clear transparent network; firm gel |
|
OG-11 |
Mod. Glutamide |
4% |
Glutamide + Octyldodecanol |
No |
Highly uniform; clear gel |
|
BOG-1 |
Ethyl cellulose + Waxes |
6% : 4% |
Hydrocel-EC + C30 Wax |
No |
Enhanced firmness; smooth structure |
|
BOG-2 |
Ellamera + Silica |
5% : 3% |
Ellamera + Aerosil |
No |
Excellent clarity; enhanced yield value |
|
HOG-1 |
Polymeric-Wax Hybrid |
5% : 5% |
Ethyl cellulose + Kester Wax |
No |
Optimal firmness; clean spreadability |
|
HOG-2 |
Polymeric-LMWG Hybrid |
4% : 2% |
Ellamera + Glutamide Blend |
No |
Self-healing properties; clear structural recovery |
|
HOG-3 |
Multi-Component Hybrid |
4%:3%:2%:1% |
Ethyl cellulose+Kester+TAISECT+Silica |
No |
Structurally robust matrix; zero oil syneresis |
3.2 Viscosity Profiles
|
Formulation Code |
Structuring System |
Spindle Selection |
Speed (RPM) |
Torque (%) |
Dynamic Viscosity (cP) |
|
OG-1 |
C30 Resin Wax |
Helipath 96 |
10 |
10.4% |
104,000 |
|
OG-2 |
Dextrin Palmitate |
RV-6 |
10 |
36.5% |
365,000 |
|
OG-3 |
TAISECT OG-C MB |
RV-6 |
10 |
27.6% |
27,166 |
|
OG-4 |
Ellamera Bi-Thin 602 |
RV-6 |
10 |
28.3% |
28,833 |
|
OG-5 |
Kester Wax K80P Blend |
RV-4 |
10 |
57.0% |
5,706 |
|
OG-7 |
Septon 4055 Polymer |
RV-6 |
10 |
48.6% |
48,633 |
|
OG-8 |
Fused Colloidal Silica |
Helipath 96 |
10 |
66.4% |
664,000 |
|
OG-10 |
Binary Glutamide Matrix |
RV-6 |
10 |
21.2% |
21,200 |
|
OG-11 |
Glutamide + Solvent |
RV-6 |
10 |
21.2% |
21,200 |
|
OG-9 |
SAFICOIL System |
RV-7 |
20 |
34.3% |
34,733 |
|
OG-6 |
Ethyl cellulose Network |
RV-6 |
10 |
48.3% |
48,633 |
|
HOG-3 |
Multi-Component Hybrid |
RV-7 |
10 |
51.4% |
514,000 |
3.3 Textural Evaluation Profiles
|
Formulation Code |
Core Gelator Entity |
Compressive Firmness (g) |
Work of Shear (g·sec) |
Absolute Neg Force (g) |
Dominant Network Mechanism |
|
OG-1 |
C30 Resin Wax |
510.540 |
352.696 |
-533.556 |
Crystalline Junction |
|
OG-2 |
Dextrin Palmitate |
135.658 |
93.461 |
-117.754 |
Polymeric Association |
|
OG-3 |
TAISECT OG-C MB |
202.801 |
101.425 |
-131.482 |
Lipophilic Assembly |
|
OG-4 |
Ellamera Bi-Thin |
213.297 |
139.636 |
-364.206 |
Chain Entanglement |
|
OG-5 |
Kester Wax Combination |
81.114 |
48.366 |
-100.436 |
Interconnected Crystals |
|
OG-7 |
Septon 4055 |
218.551 |
127.978 |
-336.382 |
Elastomeric Entanglement |
|
OG-8 |
Colloidal Silica |
2812.149 |
2998.677 |
-1945.108 |
Particulate Percolation |
|
OG-10 |
Pure Glutamides |
536.601 |
378.183 |
Truncated |
Fibrillar Self-Assembly |
|
OG-11 |
Glutamide + Solvent |
536.601 |
378.183 |
Truncated |
Solvated Fibrillar Assembly |
|
OG-9 |
SAFICOIL Agent |
328.611 |
296.485 |
-270.408 |
Metallic Soap Mesh |
|
OG-6 |
Ethyl cellulose |
821.925 |
647.234 |
-439.855 |
Viscoelastic Continuum |
|
HOG-3 |
Advanced Multi-Hybrid |
642.310 |
412.155 |
-388.420 |
Interlinking Multi-Mechanism |
SUMMARY AND CONCLUSION
Advanced hybrid oleogels were successfully developed and structurally characterized using combinations of polymeric, wax-based, supramolecular, and particulate structuring agents [cite: 1]. In these hybrid networks, the polymer chains provide an elastic scaffold, crystalline waxes introduce stable structural nodes, and supramolecular arrays form responsive bridges throughout the lipid phase [cite: 1]. The optimized hybrid formulations exhibited high visual uniformity, robust viscosity profiles, excellent oil immobilization, and favorable spreadability [cite: 1]. These characteristics indicate that hybrid oleogels represent a versatile, stable, and highly adaptable platform well-suited for pharmaceutical, cosmeceutical, and nutraceutical applications [cite: 1].
REFERENCES
Neel Tilwani, Dr. Santosh Jain, Dr. Prachi Jain, Dr. Hiral Majumdar, Mr. R. S. Dukare, Jayesh Tilwani, Formulation and Evaluation of Advanced Oleogel Technology for Pharmaceutical, Nutraceutical, and Cosmeceutical Applications, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 10, 1509-1515, https://doi.org/10.5281/zenodo.23314632
10.5281/zenodo.23314632